The stock of Tonix Pharmaceuticals Holding Corp (TNXP) has gone down by -46.01% for the week, with a -50.29% drop in the past month and a -55.18% drop in the past quarter. The volatility ratio for the week is 28.94%, and the volatility levels for the past 30 days are 12.74% for TNXP. The simple moving average for the last 20 days is -46.87% for TNXP stock, with a simple moving average of -74.75% for the last 200 days.
Is It Worth Investing in Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Right Now?
The 36-month beta value for TNXP is at 2.27. Analysts have varying views on the stock, with 2 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for TNXP is 80.81M, and currently, shorts hold a 1.20% of that float. The average trading volume for TNXP on April 01, 2024 was 1.46M shares.
TNXP) stock’s latest price update
The stock price of Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has plunged by -43.10 when compared to previous closing price of 0.33, but the company has seen a -46.01% decline in its stock price over the last five trading sessions. InvestorPlace reported 2024-03-24 that Here’s the deal with stocks to turn $1,000 into $1 million: if you want to play, you gotta pay. I’m not just talking about the price of the securities themselves.
Analysts’ Opinion of TNXP
ROTH Capital, on the other hand, stated in their research note that they expect to see TNXP reach a price target of $4. The rating they have provided for TNXP stocks is “Buy” according to the report published on April 18th, 2019.
ROTH Capital gave a rating of “Buy” to TNXP, setting the target price at $6 in the report published on August 18th of the previous year.
TNXP Trading at -45.03% from the 50-Day Moving Average
After a stumble in the market that brought TNXP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -95.35% of loss for the given period.
Volatility was left at 12.74%, however, over the last 30 days, the volatility rate increased by 28.94%, as shares sank -50.82% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -34.76% lower at present.
During the last 5 trading sessions, TNXP fell by -46.01%, which changed the moving average for the period of 200-days by -89.31% in comparison to the 20-day moving average, which settled at $0.3405. In addition, Tonix Pharmaceuticals Holding Corp saw -53.85% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for TNXP
Current profitability levels for the company are sitting at:
- -3.27 for the present operating margin
- 0.13 for the gross margin
The net margin for Tonix Pharmaceuticals Holding Corp stands at -3.29. The total capital return value is set at -1.02. Equity return is now at value -69.20, with -63.37 for asset returns.
Based on Tonix Pharmaceuticals Holding Corp (TNXP), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -88.66. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is 47.33.
Currently, EBITDA for the company is -112.09 million with net debt to EBITDA at 0.05. When we switch over and look at the enterprise to sales, we see a ratio of 0.24. The receivables turnover for the company is 24.26for trailing twelve months and the total asset turnover is 0.27. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.77.
Conclusion
In conclusion, Tonix Pharmaceuticals Holding Corp (TNXP) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
